Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

672
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
672
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Causality in Epidemiology01:21

Causality in Epidemiology

347
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
347
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

196
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
196
Prevalence and Incidence01:08

Prevalence and Incidence

394
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
394

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Grape Seed Proanthocyanidin Extract (GSPE) Mitigates Preterm White Matter Injury in Mice Via Improving Mitochondrial Homeostasis and Activity of IMMP2L-Related Signaling Pathway.

Neurochemical research·2026
Same author

Robot-Assisted Adaptive Control Enhances Dental Drilling Force Stability.

International dental journal·2026
Same author

<i>Vitellogenin-3-like</i> and <i>Vitellogenin receptor</i> Genes Involved in the Regulation of Ovarian Development and Oviposition in <i>Diaphorina citri</i>.

Insects·2026
Same author

Preclinical Research on Bacteriophage Therapy for Carbapenem-Resistant Klebsiella Pneumoniae: A Systematic Review.

Combinatorial chemistry & high throughput screening·2026
Same author

A blood-urine regulatory axis: Tumor-derived factors reprogram urine-derived stem cells via CXCL2/CXCR2/ERK signaling to drive bladder cancer stemness.

Cancer letters·2026
Same author

Interaction of Dietary Patterns and Physical Activity with Low Back Pain in Pre- to Post-Menopause: A Cross-Sectional Study.

Journal of health, population, and nutrition·2026

Related Experiment Video

Updated: Jun 13, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Comorbidity progression analysis: patient stratification and comorbidity prediction using temporal comorbidity

Ye Liang1, Chonghui Guo1, Hailin Li2,3

  • 1Institute of Systems Engineering, Dalian University of Technology, Dalian, Liaoning China.

Health Information Science and Systems
|September 16, 2024
PubMed
Summary

This study introduces a framework to analyze comorbidity progression using temporal comorbidity networks (TCN). It helps identify patient subgroups and predict future comorbidities, improving healthcare insights.

Keywords:
Comorbidity predictionComorbidity progressionElectronic health recordsPatient stratificationTemporal comorbidity network

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Related Experiment Videos

Last Updated: Jun 13, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Area of Science:

  • Medical Informatics
  • Computational Biology
  • Health Services Research

Background:

  • Understanding comorbidity progression is crucial for effective patient management and personalized treatment strategies.
  • Existing methods often lack the ability to capture dynamic temporal patterns of disease co-occurrence.
  • Identifying distinct population-specific comorbidity trajectories is essential for timely intervention.

Purpose of the Study:

  • To develop and validate a framework for analyzing comorbidity progression patterns using temporal comorbidity networks (TCN).
  • To enable timely detection of potential comorbidities and enhance understanding of comorbid condition development.
  • To stratify patients into distinct subgroups based on their comorbidity progression.

Main Methods:

  • Constructed temporal comorbidity networks (TCN) from longitudinal patient diagnosis data.
  • Utilized TCN for patient stratification through preliminary and prescription analysis.
  • Developed a distance-matched temporal comorbidity network (TCN-DM) for comorbidity prediction by identifying similar patients.

Main Results:

  • The framework successfully identified four distinct heart failure (HF) subgroups using the MIMIC-III dataset.
  • TCN revealed significant comorbidity progression patterns within these HF patient subgroups.
  • The TCN-DM method outperformed other approaches in comorbidity prediction, achieving F1-Scores between 0.454 and 0.612.

Conclusions:

  • The proposed framework effectively identifies population-specific comorbidity patterns and predicts future comorbidity developments.
  • This approach offers valuable insights for both individual patient care and population health management.
  • The TCN-DM method shows promise for improving the accuracy of comorbidity prediction in clinical settings.